CAMT:TASECamtek Ltd Analysis
Data as of 2026-06-28 - not real-time
$153.72
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Camtek Ltd. (CAMT) is trading at $153.72, which sits below its 20‑day (≈176.96) and 50‑day (≈179.59) simple moving averages, signaling short‑term weakness, while still above its 200‑day average (142.75) indicating a longer‑term base. The RSI of 40 suggests the stock is approaching oversold territory, but the MACD histogram is negative and the signal line is bearish, reinforcing a near‑term downside bias. Volatility is extreme, with a 30‑day price swing of roughly 96% and a beta exceeding 2.5, meaning CAMT moves more than twice as sharply as the market, amplifying both upside and downside risk. Fundamentally, the current PE of 158 dwarfs the industry average of 36, flagging significant overvaluation, yet the forward PE of 34 aligns more closely with peers, supported by a jump in forward EPS to $4.52 from $0.97. The balance sheet is strong – cash of $670 M exceeds debt of $488 M – and operating margins remain healthy (~22%). A material catalyst emerged as the company secured $105 M of AI‑focused inspection orders, driving an 8.2% price surge and underpinning the analyst median target of $187.5, implying roughly a 22% upside. Overall, the stock presents a mixed picture: high short‑term technical pressure, substantial valuation stretch, but a compelling growth narrative from AI‑driven demand and solid fundamentals.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below 20‑day and 50‑day SMAs
- Bearish MACD and neutral trend
- Extreme short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward PE of 34 aligns with industry
- Recent $105 M AI inspection order pipeline
- Strong cash position and improving earnings outlook
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Secular growth in semiconductor equipment market
- Sustainable operating margins and low debt ratio
- Persistently high valuation relative to current earnings
Key Metrics & Analysis
Financial Health
Revenue Growth2.50%
Profit Margin9.63%
P/E Ratio158.5
ROE7.56%
ROA7.08%
Debt/Equity71.47
P/B Ratio10.4
Industry P/E36.1
Technical Analysis
TrendNeutral
RSI40.1
Support$153.18
Resistance$204.49
MA 20$176.96
MA 50$179.59
MA 200$142.75
MACDBearish
VolumeStable
Fear & Greed Index88.55
Valuation
Target Price$187.25
Upside/Downside21.81%
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.54
Volatility96.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.